|
DHX16 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.258000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.326060E-02 |
| Normal-vs-Stage2 |
9.142200E-01 |
| Normal-vs-Stage3 |
9.840800E-01 |
| Normal-vs-Stage4 |
2.502200E-01 |
| Stage1-vs-Stage2 |
1.603640E-01 |
| Stage1-vs-Stage3 |
4.220400E-02 |
| Stage1-vs-Stage4 |
5.625000E-01 |
| Stage2-vs-Stage3 |
9.290800E-01 |
| Stage2-vs-Stage4 |
4.577800E-01 |
| Stage3-vs-Stage4 |
3.027800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.159800E-01 |
| Normal-vs-AfricanAmerican |
3.000800E-03 |
| Normal-vs-Asian |
1.016400E-04 |
| Caucasian-vs-AfricanAmerican |
2.900300E-03 |
| Caucasian-vs-Asian |
3.197700E-02 |
| AfricanAmerican-vs-Asian |
1.729580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.560800E-01 |
| Normal-vs-Female |
8.48970000000282E-05 |
| Male-vs-Female |
3.6543E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.974800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.243870E-02 |
| Normal-vs-Age(61-80Yrs) |
3.929600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.914600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.741800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.252600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.643000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.878300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.578400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.626600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.96309998759625E-09 |
| Normal-vs-Grade 2 |
8.678100E-03 |
| Normal-vs-Grade 3 |
4.958400E-01 |
| Normal-vs-Grade 4 |
2.225200E-01 |
| Grade 1-vs-Grade 2 |
3.884100E-03 |
| Grade 1-vs-Grade 3 |
8.27650000000402E-05 |
| Grade 1-vs-Grade 4 |
1.25979999998638E-06 |
| Grade 2-vs-Grade 3 |
4.888200E-02 |
| Grade 2-vs-Grade 4 |
1.260670E-03 |
| Grade 3-vs-Grade 4 |
9.162200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.198800E-04 |
| Normal-vs-ccB subtype |
6.894400E-02 |
| ccA subtype-vs-ccB subtype |
1.47339999978513E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.512300E-02 |
| Normal-vs-N1 |
7.851600E-01 |
| N0-vs-N1 |
3.835800E-01 |
|
|
